Pseudouridine is the most abundant RNA modification, but its biological role remains poorly understood. A study now finds dysregulated pseudouridine synthase PUS7 in glioblastoma and demonstrates that pharmacological inhibition of PUS7 leads to reduced tumorigenesis, which underpins the therapeutic potential of targeting epitranscriptomic regulators in cancer.
This is a preview of subscription content, log in via an institution to check access.
References
Cohn, W. E. & Volkin, E. Nature 167, 483–484 (1951).
Spenkuch, F., Motorin, Y. & Helm, M. RNA Biol. 11, 1540–1554 (2014).
Nombela, P., Miguel-Lopez, B. & Blanco, S. Mol. Cancer 20, 18 (2021).
Cui, Q. et al. Nat. Cancer https://doi.org/10.1038/s43018-021-0238-0 (2021).
Lathia, J. D. et al. Genes Dev. 29, 1203–1217 (2015).
Marine, J. C., Dawson, S. J. & Dawson, M. A. Nat. Rev. Cancer 20, 743–756 (2020).
Heiss, N. S. et al. Nat. Genet. 19, 32–38 (1998).
Guzzi, N. et al. Cell 173, 1204–1216.e1226 (2018).
Krstulja, A. et al. Macromol. Biosci. 17, 1700250 (2017).
Zeleznik, O. A. et al. Cancer Res. 80, 1357–1367 (2020).
Sridharan, G., Ramani, P., Patankar, S. & Vijayaraghavan, R. J. Oral Pathol. Med. 48, 299–306 (2019).
Su, R. et al. Cell 172, 90–105.e123 (2018).
Yankova, E. et al. Nature 593, 597–601 (2021).
Cui, Q. et al. Cell Rep. 18, 2622–2634 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Morón-Calvente, V., Blanco, S. A therapy PUSh for GBM. Nat Cancer 2, 876–878 (2021). https://doi.org/10.1038/s43018-021-00255-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-021-00255-z
- Springer Nature America, Inc.